Ternary Therapeutics
Latest round
- Seed
Last raised
- Mar 2026
Total raised
- $4.8M
Investors
- 4
About Ternary Therapeutics
Founded in 2024, Ternary Therapeutics Ltd operates out of London, UK, specializing in the creation of molecular glue degraders and activators. The founder's background includes previous ventures in the biotech sector, although specific details are not available.Ternary Therapeutics specializes in the development of molecular glue degraders and activators, utilizing a proprietary computational design platform to drive innovation. Their technology addresses complex biological challenges by identifying hot spots on protein surfaces for ternary complex formation. This facilitates the rational design of therapeutic agents to be used in drug discovery efforts.Ternary Therapeutics generates revenue primarily through partnerships and collaborations with the pharmaceutical industry, engaging in B2B transactions with biotech companies and research institutions. Their revenue structure includes licensing agreements and project-based collaborations, allowing access to their innovative technology for molecular glue design.6 million on March 16, 2026, Ternary Therapeutics plans to expand its computational and laboratory teams to advance its lead programmes towards preclinical development. The company aims to introduce new products designed to enhance drug discovery and plans to target expansion in North America and Asia by 2027, leveraging its growing expertise and resources to penetrate these key markets.
Who invested in Ternary Therapeutics
4 investors across 1 round
See all investors in Ternary Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 16, 2026
Amount
$4.8M
Investors
Questions about Ternary Therapeutics
Who invested in Ternary Therapeutics?
Ternary Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ternary Therapeutics raised?
Ternary Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ternary Therapeutics last raise money?
Ternary Therapeutics's most recent round on record is a Seed, in Mar 2026.
What does Ternary Therapeutics do?
Founded in 2024, Ternary Therapeutics Ltd operates out of London, UK, specializing in the creation of molecular glue degraders and activators.
Where is Ternary Therapeutics headquartered?
Ternary Therapeutics is headquartered in London, UK.
Which VCs invest in companies like Ternary Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Ternary Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Ternary Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.